Taurine declines 80% between youth and old age. A 2023 Science paper showed taurine supplementation extended lifespan in mice and worms, and improved healthspan markers in primates. Clinical doses of 1–6 g/day appear safe and are used in integrative longevity protocols.

Taurine is an amino acid your body makes less of as you get older. Scientists found that giving older animals more taurine helped them live longer and stay healthier. Doctors now use taurine supplements as part of aging-prevention plans.

At a Glance

Parameter	Detail
Compound	Taurine (2-aminoethanesulfonic acid)
Classification	Conditionally essential sulfonic amino acid
Age-related decline	~80% reduction from youth to old age (plasma)
Evidence tier	Animal lifespan data; observational human data
Common clinical dose	1–6 g/day oral; divided dosing preferred
Key mechanisms	Mitochondrial protection, ER stress reduction, inflammation, DNA integrity
Safety profile	Favorable at ≤6 g/day; renally cleared
Best candidate	Adults 40+, metabolic syndrome, cardiovascular risk, mitochondrial dysfunction

When a paper lands in Science and generates mainstream health headlines, I read it carefully before I change what I recommend to patients. The 2023 Yadav et al. study on taurine did exactly that — and after reviewing it alongside existing cardiology, neurology, and metabolism literature, I concluded it deserved a place in the longevity discussion I have with most patients over 45.

Taurine is not a new molecule. It has been studied in cardiovascular disease, diabetes, and liver health for decades. What shifted in 2023 was the framing: this is not just a supportive nutrient — it may be a direct regulator of the pace at which we age. That is a different claim, and it warrants a careful, evidence-graded look.

What Is Taurine, and Why Does It Fall With Age?

Taurine is a sulfonic amino acid found in high concentrations in the heart, skeletal muscle, brain, and retina. Unlike most amino acids, it is not incorporated into proteins; instead, it functions as a free intracellular molecule that regulates osmolarity, mitochondrial function, calcium signaling, and antioxidant defense.

The human body synthesizes taurine from methionine and cysteine via the cysteine sulfinic acid pathway. Biosynthesis capacity is meaningful but limited, particularly in tissues with high oxidative demand. Dietary sources — primarily meat, fish, and shellfish — contribute substantially to plasma levels, which is one reason omnivores consistently show higher taurine status than vegans.

What makes taurine clinically interesting from a longevity standpoint is the documented, steep age-related decline. Yadav and colleagues measured taurine in the plasma and tissues of multiple species and found that plasma taurine in humans falls by roughly 80% between early adulthood and old age. This is not a marginal change — it is a collapse in a molecule that appears to be doing significant regulatory work.

The question the 2023 study set out to answer was whether that decline is merely a correlate of aging, or whether it is a driver — and whether restoring it could change biological outcomes.

The 2023 Science Paper: What It Actually Showed

Yadav et al. published “Taurine deficiency as a driver of aging” in Science (June 2023). The study was multi-species and multi-model, which strengthens its translational relevance.

Animal Lifespan Findings

In C. elegans (roundworms), taurine supplementation extended median lifespan by approximately 10–23% depending on dose. In mice, daily taurine supplementation starting at middle age (14 months, roughly equivalent to ~45 years in humans) extended median lifespan by 10–12% in females and a similar magnitude in males. Critically, the treated animals did not merely live longer — they showed significantly better healthspan markers: improved bone density, muscle endurance, reduced fat accumulation, better glucose tolerance, and lower systemic inflammation.

Non-Human Primate Data

Middle-aged rhesus monkeys supplemented with taurine over six months showed improved energy expenditure, reduced fasting glucose, better insulin sensitivity, lower inflammatory cytokines, and increased bone density compared to controls. This is the most translationally relevant dataset in the paper, because primate metabolism and aging timelines are far closer to human biology than rodent models.

Human Observational Data

The study did not include a randomized controlled trial in humans — that limitation matters and I will come back to it. What it did include was an epidemiological analysis from a large European cohort showing that higher circulating taurine levels correlated with lower rates of type 2 diabetes, obesity, hypertension, and inflammatory markers. Cross-sectional correlations cannot establish causation, but they align directionally with the interventional animal data.

My interpretation: The animal evidence is among the more compelling I have seen for a single longevity-related molecule in recent years. The primate data is particularly persuasive. Human RCT data on lifespan outcomes does not exist and may never exist given practical constraints — but the mechanistic and observational picture supports cautious clinical interest.

Mechanisms: How Taurine Influences the Biology of Aging

The study identified several pathways through which taurine appears to regulate biological aging. These are worth understanding individually.

Mitochondrial Function

Taurine is required for the post-transcriptional modification of mitochondrial tRNA, specifically the wobble uridine modification. Without adequate taurine, mitochondrial protein synthesis becomes error-prone, electron transport chain function degrades, and ATP production efficiency falls. This is a deep mechanistic link: taurine deficiency creates mitochondrial dysfunction at the translational level.

In aging tissues, mitochondrial dysfunction is a hallmark feature. Taurine supplementation in older animals partially reversed this decline, improving oxygen consumption rates and reducing mitochondrial reactive oxygen species.

Endoplasmic Reticulum Stress Reduction

The endoplasmic reticulum (ER) is responsible for protein folding. Under chronic stress — from oxidative load, nutrient excess, inflammation — the ER triggers the unfolded protein response (UPR), which contributes to cellular senescence and organ dysfunction. Taurine acts as a chemical chaperone that reduces ER stress burden. This is particularly relevant to pancreatic beta cells, hepatocytes, and neurons — tissues where ER stress is a significant driver of age-related pathology.

Telomere Protection and DNA Integrity

Taurine-supplemented animals in the Yadav study showed longer leukocyte telomeres and reduced markers of DNA damage compared to controls. The mechanism appears to involve both direct antioxidant effects and downstream reduction in cellular senescence burden.

Inflammation and Inflammaging

Circulating IL-6, TNF-alpha, and other pro-inflammatory cytokines were lower in taurine-supplemented animals. “Inflammaging” — the chronic low-grade inflammatory state that characterizes aging — is now understood as a key driver of most age-related diseases. Taurine’s anti-inflammatory effects appear to operate through multiple nodes: reduced NF-κB signaling, decreased macrophage activation, and improved gut barrier function.

Taurine Across Key Organ Systems

Cardiovascular

Taurine has the most robust pre-existing clinical literature in cardiovascular disease. Meta-analyses published prior to the 2023 paper had already established clinically meaningful blood pressure lowering (approximately 3–4 mmHg systolic), reduced LDL oxidation, and improved left ventricular function in patients with congestive heart failure. A Japanese prospective cohort linked higher taurine intake to significantly lower cardiovascular mortality. For patients managing hypertension, heart failure, or metabolic risk, the cardiovascular case for taurine supplementation was already reasonably strong before longevity data emerged.

Metabolic and Hepatic

Taurine improves insulin sensitivity through AMPK activation and reduces hepatic fat accumulation in non-alcoholic fatty liver disease (NAFLD). In patients with metabolic syndrome — a population I see frequently — taurine at 1.5–3 g/day has been shown in small RCTs to reduce fasting glucose, triglycerides, and liver enzyme elevation. This is clinically actionable evidence that does not require waiting for human longevity trials.

Neurological

Brain taurine levels fall significantly with age and more acutely in neurodegenerative conditions. Taurine acts as a neuromodulator at GABA-A and glycine receptors, contributing to inhibitory neurotransmission and neuroprotection. In preclinical models of Alzheimer’s and Parkinson’s disease, taurine supplementation reduced amyloid burden, improved cognitive performance, and attenuated dopaminergic neuron loss. Human data in neurodegeneration remains early, but the mechanistic basis is sound and the risk profile is low enough to consider in patients with cognitive concern.

Musculoskeletal

Taurine is the most abundant free amino acid in skeletal muscle. It regulates calcium handling in the sarcoplasmic reticulum and protects muscle from exercise-induced oxidative damage. Athletes and older patients with sarcopenia may benefit from optimized taurine status, though dedicated sarcopenia trials are sparse.

Clinical Dosing and Who Benefits Most

Candidate Population

Based on current evidence, I consider taurine supplementation most clearly indicated in:

Adults over 45 with confirmed plasma taurine deficiency (testable, though not widely available)
Patients with cardiovascular disease or metabolic syndrome
Individuals on plant-based diets (lower dietary taurine intake)
Patients with NAFLD or insulin resistance
Anyone using a broader longevity supplement stack
Patients with mitochondrial dysfunction syndromes

Dosing Protocol

Most clinical studies showing benefit have used 1–3 g/day in divided doses. The Yadav animal studies used doses that extrapolate to approximately 3–6 g/day in humans based on surface area scaling. I typically start patients at 1 g twice daily with meals and assess tolerance before increasing.

There is no established upper limit from human RCT data, but the European Food Safety Authority and available toxicology suggest doses up to 6 g/day are well tolerated in healthy adults. Energy drink literature (where taurine is a common ingredient at 1–2 g per serving) provides large real-world safety datasets, albeit at lower doses.

Formulation: Taurine is absorbed well orally and does not require specialized formulation. Powder dissolved in water is cost-effective and reliable.

Timing: I prefer splitting the dose — morning and afternoon — to maintain steadier plasma levels. Taking it with food appears to improve tolerability without significantly affecting absorption.

Safety, Contraindications, and Drug Interactions

Taurine’s safety profile is one of the more favorable among active longevity compounds. It is renally excreted; patients with chronic kidney disease should use lower doses (≤1 g/day) and monitor. There are no established interactions with common pharmaceuticals, though caution is warranted with lithium (both are renally cleared and may compete for tubular transport) and potentially with diuretics.

Taurine is not a stimulant, has no addictive potential, and does not interfere with sleep at typical doses. Some patients report mild gastrointestinal discomfort at doses above 4 g/day on an empty stomach — splitting doses and taking with food resolves this in the majority.

Pregnancy and lactation data is insufficient; I do not recommend supplementation during these periods beyond dietary taurine from food sources.

Taurine in Context: How It Fits a Longevity Stack

Taurine is not a standalone longevity intervention — no single compound is. Its mechanisms complement several other evidence-supported strategies I use clinically:

With NAD+ precursors (NMN/NR): Both target mitochondrial function through different pathways. Taurine addresses translation-level mitochondrial fidelity; NAD+ precursors support the SIRT/PARP system. They are non-redundant and potentially synergistic.
With Urolithin A: Both improve mitochondrial quality — taurine through biogenesis support and oxidative protection; Urolithin A through mitophagy. Combined, they address input and output of mitochondrial health.
With senolytics (quercetin, fisetin): Taurine reduces the senescent cell burden through anti-inflammatory pathways; senolytics clear established senescent cells. Different mechanisms, complementary effect.
With Zone 2 exercise: Exercise is the most potent known taurine-depleting activity; regular aerobic training may benefit from taurine co-supplementation to support muscular recovery and mitochondrial adaptation.

The evidence hierarchy for taurine currently sits below exercise, sleep, and caloric management as longevity interventions — but above most single-pathway supplements. The 2023 data moved it meaningfully up my clinical priority list.

References

Yadav A, et al. “Taurine deficiency as a driver of aging.” Science. 2023;380(6649):eabn9257. doi:10.1126/science.abn9257
Ripps H, Shen W. “Review: taurine: a ‘very essential’ amino acid.” Mol Vis. 2012;18:2673-2686.
Ahmadian M, et al. “Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure patients.” Ther Adv Cardiovasc Dis. 2017;11(7):185-194. doi:10.1177/1753944717711138
Rosa FT, et al. “Evidences for anti-inflammatory effects of taurine in skeletal muscle.” Amino Acids. 2014;46(6):1307-1317. doi:10.1007/s00253-013-5399-3
Zulli A, et al. “High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery.” Hypertension. 2009;53(6):1017-1022. doi:10.1161/HYPERTENSIONAHA.108.122408
Schaffer SW, et al. “Effect of taurine deficiency on calcium homeostasis in isolated cardiomyocytes.” J Mol Cell Cardiol. 2010;48(2):354-361. doi:10.1016/j.yjmcc.2009.09.021
Jong CJ, et al. “The role of taurine in mitochondria health: more than just an antioxidant.” Molecules. 2021;26(16):4913. doi:10.3390/molecules26164913

Taurine and Longevity: A Physician's Evidence Review